Intracranial Stenting in Non-acute Symptomatic Ischemic Stroke
Status:
Recruiting
Trial end date:
2022-05-24
Target enrollment:
Participant gender:
Summary
In non-acute symptomatic ischemic stroke, the decision-making of medical treatment plus
intracranial stenting has been more and more popular, especially in patients with
intracranial large severe stenosis or occlusive artery. Nonetheless, there is no evidence
from randomized controlled trials evaluating the efficacy of this treatment after the
Wingspan Stent System Post Market Surveillance (WEAVE) and Wingspan One Year Vascular Imaging
Events and Neurologic Outcomes (WOVEN) trial compared with medical treatment alone. This
trial was to investigate whether medical treatment plus intracranial stenting would prevent
the recurrent ischemic stroke in the territory of the symptomatic intracranial artery during
1-year follow-up.